Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Vidarabine | hsa00010 | Glycolysis / Gluconeogenesis | 4.41E-02 | 4 | P04075, P06733, P04406, P60174 | ALDOA, ENO1, GAPDH, TPI1 | More | | Vidarabine | hsa00030 | Pentose phosphate pathway | 6.59E-05 | 5 | P60891, P51854, P08237, P52209, P37837 | PRPS1, TKTL1, PFKM, PGD, TALDO1 | More | | Vidarabine | hsa00051 | Fructose and mannose metabolism | 2.21E-02 | 3 | O14772, P60174, P04075 | FPGT, TPI1, ALDOA | More | | Vidarabine | hsa00052 | Galactose metabolism | 1.51E-04 | 3 | P06280, O43451, P35557 | GLA, MGAM, GCK | More | | Vidarabine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Vidarabine | hsa00100 | Steroid biosynthesis | 4.70E-02 | 1 | P35610 | SOAT1 | More | | Vidarabine | hsa00120 | Primary bile acid biosynthesis | 3.72E-02 | 2 | P22680, P22307 | CYP7A1, SCP2 | More | | Vidarabine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | | Vidarabine | hsa00220 | Arginine biosynthesis | 3.73E-03 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Vidarabine | hsa00230 | Purine metabolism | 2.15E-03 | 5 | Q7LG56, P31350, P51828, P21589, Q9Y227 | RRM2B, RRM2, ADCY7, NT5E, ENTPD4 | More | | Vidarabine | hsa00240 | Pyrimidine metabolism | 6.73E-10 | 7 | Q7LG56, P31350, Q9Y227, P21589, P32320, P04183, P04818 | RRM2B, RRM2, ENTPD4, NT5E, CDA, TK1, TYMS | More | | Vidarabine | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | | Vidarabine | hsa00280 | Valine, leucine and isoleucine degradation | 3.41E-03 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Vidarabine | hsa00310 | Lysine degradation | 3.73E-03 | 3 | Q96KQ7, Q02809, P51648 | EHMT2, PLOD1, ALDH3A2 | More | | Vidarabine | hsa00340 | Histidine metabolism | 4.52E-02 | 1 | O95954 | FTCD | More | | Vidarabine | hsa00410 | beta-Alanine metabolism | 3.98E-02 | 1 | Q6ZQY3 | GADL1 | More | | Vidarabine | hsa00440 | Phosphonate and phosphinate metabolism | 3.98E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Vidarabine | hsa00471 | D-Glutamine and D-glutamate metabolism | 6.90E-04 | 2 | Q7Z3D6, P49448 | C14orf159, GLUD2 | More | | Vidarabine | hsa00480 | Glutathione metabolism | 3.36E-05 | 6 | Q9UJ14, Q16772, P09211, Q7LG56, P31350, P30041 | GGTL3, GSTA3, GSTP1, RRM2B, RRM2, PRDX6 | More | | Vidarabine | hsa00500 | Starch and sucrose metabolism | 2.00E-08 | 4 | O43451, P46976, P35557, P06737 | MGAM, GYG1, GCK, PYGL | More | | Vidarabine | hsa00512 | Mucin type O-glycan biosynthesis | 1.31E-03 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Vidarabine | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 8.73E-04 | 1 | P35557 | GCK | More | | Vidarabine | hsa00531 | Glycosaminoglycan degradation | 4.51E-02 | 2 | P22304, P06865 | IDS, HEXA | More | | Vidarabine | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | | Vidarabine | hsa00564 | Glycerophospholipid metabolism | 4.77E-05 | 5 | P48651, Q9Y6K0, P35790, Q9Y259, P49619 | PTDSS1, CEPT1, CHKA, CHKB, DGKG | More | | Vidarabine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Vidarabine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Vidarabine | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Vidarabine | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | | Vidarabine | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | | Vidarabine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.96E-09 | 2 | P40925, P15104 | MDH1, GLUL | More | | Vidarabine | hsa00730 | Thiamine metabolism | 2.53E-04 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Vidarabine | hsa00740 | Riboflavin metabolism | 3.98E-02 | 1 | Q969G6 | RFK | More | | Vidarabine | hsa00750 | Vitamin B6 metabolism | 4.45E-02 | 1 | O00764 | PDXK | More | | Vidarabine | hsa00770 | Pantothenate and CoA biosynthesis | 3.98E-02 | 1 | Q6ZQY3 | GADL1 | More | | Vidarabine | hsa00900 | Terpenoid backbone biosynthesis | 3.05E-02 | 1 | Q01581 | HMGCS1 | More | | Vidarabine | hsa00910 | Nitrogen metabolism | 4.88E-02 | 1 | P49448 | GLUD2 | More | | Vidarabine | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Vidarabine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 8.69E-06 | 5 | Q16772, P78417, P11766, P09211, P11712 | GSTA3, GSTO1, ADH5, GSTP1, CYP2C9 | More | | Vidarabine | hsa00982 | Drug metabolism - cytochrome P450 | 1.66E-05 | 5 | P11712, Q16772, P09211, P78417, P11766 | CYP2C9, GSTA3, GSTP1, GSTO1, ADH5 | More | | Vidarabine | hsa00983 | Drug metabolism - other enzymes | 2.72E-10 | 7 | P04183, P32320, Q7LG56, P31350, P05164, Q16772, P09211 | TK1, CDA, RRM2B, RRM2, MPO, GSTA3, GSTP1 | More | | Vidarabine | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.28E-02 | 1 | P22307 | SCP2 | More | | Vidarabine | hsa01100 | Metabolic pathways | 6.27E-05 | 41 | Q9Y234, P35790, Q9Y259, Q16772, P09211, Q9UJ14, P15144, P30041, O14732, Q13956, Q02153, Q16774, P20839, P00918, P40926, P10768, P55809, P06280, Q7KZN9, Q9Y6K0, P15121, P08237, P49619, P21399, O95954, Q02318, Q9UHK6, P51854, Q86VZ5, Q9BVK2, P15907, Q9UBX8, O96024, P37837, P50213, P43490, P35573, Q9BQB6, Q969G6, Q13029, Q9NVH6 | LIPT1, CHKA, CHKB, GSTA3, GSTP1, GGTL3, ANPEP, PRDX6, IMPA2, PDE6H, GUCY1B3, GUK1, IMPDH1, CA2, MDH2, ESD, OXCT1, GLA, COX15, CEPT1, AKR1B1, PFKM, DGKG, ACO1, FTCD, CYP27A1, AMACR, TKTL1, SGMS1, ALG8, ST6GAL1, B4GALT6, B3GALT4, TALDO1, IDH3A, PBEF1, AGL, VKORC1, RFK, PRDM2, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.778 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P35790 | CHKA | Choline kinase alpha | -0.856 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P35790 | CHKA | Choline kinase alpha | -0.717 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q9Y259 | CHKB | Choline/ethanolamine kinase | -0.751 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.768 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.793 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P09211 | GSTP1 | Glutathione S-transferase P | 0.712 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.748 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P15144 | ANPEP | Aminopeptidase N | 0.846 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.785 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.75 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | O14732 | IMPA2 | Inositol monophosphatase 2 | 0.738 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0.703 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.774 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q16774 | GUK1 | Guanylate kinase | 0.757 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 1 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P00918 | CA2 | Carbonic anhydrase 2 | 0.772 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | 0.81 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P10768 | ESD | S-formylglutathione hydrolase | -0.701 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.744 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P06280 | GLA | Alpha-galactosidase A | 0.728 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q7KZN9 | COX15 | Cytochrome c oxidase assembly protein COX15 homolog | 0.764 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.771 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 1 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.868 | P11388 | TOP2A | DNA topoisomerase 2-alpha | P49619 | DGKG | Diacylglycerol kinase gamma | 0.926 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P21399 | ACO1 | Cytoplasmic aconitate hydratase | -0.739 | P11388 | TOP2A | DNA topoisomerase 2-alpha | O95954 | FTCD | Formimidoyltransferase-cyclodeaminase | -0.718 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q02318 | CYP27A1 | Sterol 26-hydroxylase, mitochondrial | -0.879 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.784 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.704 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P51854 | TKTL1 | Transketolase-like protein 1 | -0.753 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.81 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.736 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9BVK2 | ALG8 | Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase | -0.726 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.827 | P11388 | TOP2A | DNA topoisomerase 2-alpha | Q9UBX8 | B4GALT6 | Beta-1,4-galactosyltransferase 6 | 0.869 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | O96024 | B3GALT4 | Beta-1,3-galactosyltransferase 4 | 0.797 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P37837 | TALDO1 | Transaldolase | 0.732 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P50213 | IDH3A | Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial | -0.732 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.702 | P11388 | TOP2A | DNA topoisomerase 2-alpha | P35573 | AGL | Glycogen debranching enzyme | 0.759 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9BQB6 | VKORC1 | Vitamin K epoxide reductase complex subunit 1 | 0.731 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q969G6 | RFK | Riboflavin kinase | 0.705 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q13029 | PRDM2 | PR domain zinc finger protein 2 | 0.744 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.721 |
| Vidarabine | hsa01200 | Carbon metabolism | 3.30E-04 | 13 | P04075, P51854, P04406, P08237, P60174, P37837, P06733, O14521, Q9P2R7, P50213, P21399, P10768, Q02252 | ALDOA, TKTL1, GAPDH, PFKM, TPI1, TALDO1, ENO1, SDHD, SUCLA2, IDH3A, ACO1, ESD, ALDH6A1 | More | | Vidarabine | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.90E-05 | 2 | P21399, P50213 | ACO1, IDH3A | More | | Vidarabine | hsa01230 | Biosynthesis of amino acids | 2.62E-05 | 13 | P60174, P04406, P06733, P04075, P08237, P51854, P60891, Q99707, P21399, P50213, P05089, P15104, P37837 | TPI1, GAPDH, ENO1, ALDOA, PFKM, TKTL1, PRPS1, MTR, ACO1, IDH3A, ARG1, GLUL, TALDO1 | More | | Vidarabine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.82E-02 | 2 | P49841, P42338 | GSK3B, PIK3CB | More | | Vidarabine | hsa01522 | Endocrine resistance | 2.84E-02 | 3 | P22694, Q9UM47, P46527 | PRKACB, NOTCH3, CDKN1B | More | | Vidarabine | hsa01524 | Platinum drug resistance | 8.80E-04 | 7 | Q13489, P98170, Q16772, P09211, P78417, P43246, P52701 | BIRC3, BIRC4, GSTA3, GSTP1, GSTO1, MSH2, MSH6 | More | | Vidarabine | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Vidarabine | hsa03008 | Ribosome biogenesis in eukaryotes | 8.16E-03 | 3 | Q9NYH9, P78345, Q9GZY0 | UTP6, RPP38, NXF2; NXF2B | More | | Vidarabine | hsa03010 | Ribosome | 1.22E-02 | 2 | P46777, P50914 | RPL5, RPL14 | More | | Vidarabine | hsa03013 | RNA transport | 7.73E-04 | 13 | P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P47813, O14602, Q14152, O75822, P78345, Q9Y6A5, P51114 | NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF1AX, EIF1AY, EIF3A, EIF3J, RPP38, TACC3, FXR1 | More | | Vidarabine | hsa03015 | mRNA surveillance pathway | 3.37E-02 | 3 | O43148, Q9GZY0, P52298 | RNMT, NXF2; NXF2B, NCBP2 | More | | Vidarabine | hsa03020 | RNA polymerase | 8.48E-06 | 5 | P30876, P24928, P62487, Q9GZM3, P52435 | POLR2B, POLR2A, POLR2G, POLR2J2, POLR2J | More | | Vidarabine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Vidarabine | hsa03040 | Spliceosome | 4.37E-14 | 14 | Q14562, O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.781 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.732 | P29375 | JARID1A | Lysine-specific demethylase 5A | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.794 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.789 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.809 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P07948 | LYN | Tyrosine-protein kinase Lyn | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.814 | P29375 | JARID1A | Lysine-specific demethylase 5A | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.875 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.739 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.752 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P07948 | LYN | Tyrosine-protein kinase Lyn | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.775 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.702 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.879 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.824 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.806 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.716 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.701 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P07948 | LYN | Tyrosine-protein kinase Lyn | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.79 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.703 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.781 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.772 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.731 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P07948 | LYN | Tyrosine-protein kinase Lyn | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.732 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.734 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.872 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P07948 | LYN | Tyrosine-protein kinase Lyn | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Vidarabine | hsa03050 | Proteasome | 1.21E-02 | 1 | P28074 | PSMB5 | More | | Vidarabine | hsa03060 | Protein export | 6.86E-05 | 3 | Q15070, P37108, Q15005 | OXA1L, SRP14, SPCS2 | More | | Vidarabine | hsa03320 | PPAR signaling pathway | 1.62E-02 | 2 | Q13133, Q02318 | NR1H3, CYP27A1 | More | | Vidarabine | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Vidarabine | hsa04012 | ErbB signaling pathway | 2.82E-02 | 2 | P49841, P42338 | GSK3B, PIK3CB | More | | Vidarabine | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Vidarabine | hsa04015 | Rap1 signaling pathway | 2.64E-03 | 10 | P20827, P49767, P06213, Q96FS4, P11215, Q13009, O00522, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, INSR, SIPA1, ITGAM, TIAM1, KRIT1, RASGRP2, PIK3CB, PLCG1 | More | | Vidarabine | hsa04020 | Calcium signaling pathway | 5.11E-04 | 9 | P27987, P21796, P45880, Q13557, P30679, P19174, P0DP23, P05141, P23634 | ITPKB, VDAC1, VDAC2, CAMK2D, GNA15, PLCG1, CALM1, SLC25A5, ATP2B4 | More | | Vidarabine | hsa04022 | cGMP-PKG signaling pathway | 2.26E-03 | 8 | Q14814, Q99941, P18848, P05141, P21796, P45880, P0DP23, P01042 | MEF2D, CREBL1, ATF4, SLC25A5, VDAC1, VDAC2, CALM1, KNG1 | More | | Vidarabine | hsa04024 | cAMP signaling pathway | 4.38E-02 | 4 | P42338, P0DP23, Q13370, Q13009 | PIK3CB, CALM1, PDE3B, TIAM1 | More | | Vidarabine | hsa04060 | Cytokine-cytokine receptor interaction | 3.03E-03 | 12 | P27930, P14778, P26842, Q13651, P25024, P25025, Q9UBD3, P47992, O75509, P09341, P18510, P01730 | IL1R2, IL1R1, CD27, IL10RA, CXCR1, CXCR2, XCL2, XCL1, TNFRSF21, CXCL1, IL1RN, CD4 | More | | Vidarabine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 5.16E-04 | 10 | P51684, P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784, P01375 | CCR6, CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Vidarabine | hsa04062 | Chemokine signaling pathway | 1.72E-07 | 20 | P25024, P25025, P09341, P19875, P47992, Q9UBD3, P09769, P07948, P42338, P19174, P62873, P63218, P50151, P43250, P49407, Q08881, Q7LDG7, Q13009, P49841, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, XCL1, XCL2, FGR, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, ARRB1, ITK, RASGRP2, TIAM1, GSK3B, PIK3R5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.715 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 0.843 | Q13547 | HDAC1 | Histone deacetylase 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.803 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.892 | Q13547 | HDAC1 | Histone deacetylase 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.719 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P47992 | XCL1 | Lymphotactin | -0.796 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | -0.796 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P09769 | FGR | Tyrosine-protein kinase Fgr | 0.796 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.749 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.767 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.756 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.864 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.754 | Q13547 | HDAC1 | Histone deacetylase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.716 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.815 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.818 | P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P49407 | ARRB1 | Beta-arrestin-1 | 0.75 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.771 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.81 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.798 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 |
| Vidarabine | hsa04064 | NF-kappa B signaling pathway | 5.07E-11 | 24 | P10415, Q13489, P51617, O00463, Q13546, P14778, P01584, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q13315, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9UNE0, Q9NQC7 | BCL2, BIRC3, IRAK1, TRAF5, RIPK1, IL1R1, IL1B, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, EDAR, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q07912 | TNK2 | Activated CDC42 kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.7 | P04183 | TK1 | Thymidine kinase, cytosolic | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.763 | P32320 | CDA | Cytidine deaminase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.84 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.868 | P04183 | TK1 | Thymidine kinase, cytosolic | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.756 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.786 | P32320 | CDA | Cytidine deaminase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.888 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.735 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 0.702 | P08235 | NR3C2 | Mineralocorticoid receptor | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.749 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.923 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | P32320 | CDA | Cytidine deaminase | P01375 | TNF | Tumor necrosis factor | 0.806 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P04183 | TK1 | Thymidine kinase, cytosolic | Q04759 | PRKCQ | Protein kinase C theta type | -0.729 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P32320 | CDA | Cytidine deaminase | Q04759 | PRKCQ | Protein kinase C theta type | -0.814 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.801 | P04183 | TK1 | Thymidine kinase, cytosolic | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.738 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.708 | P32320 | CDA | Cytidine deaminase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.864 | P32320 | CDA | Cytidine deaminase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.723 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.82 | P32320 | CDA | Cytidine deaminase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.852 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.742 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.749 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.835 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | Q07912 | TNK2 | Activated CDC42 kinase 1 | Q13315 | ATM | Serine-protein kinase ATM | -0.755 | P04183 | TK1 | Thymidine kinase, cytosolic | Q13315 | ATM | Serine-protein kinase ATM | -0.765 | P32320 | CDA | Cytidine deaminase | Q13315 | ATM | Serine-protein kinase ATM | -0.748 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.756 | P04183 | TK1 | Thymidine kinase, cytosolic | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.718 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.793 | P32320 | CDA | Cytidine deaminase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.758 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P04183 | TK1 | Thymidine kinase, cytosolic | P09341 | CXCL1 | Growth-regulated alpha protein | 0.722 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | P32320 | CDA | Cytidine deaminase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.84 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P09341 | CXCL1 | Growth-regulated alpha protein | 0.78 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | Q06643 | LTB | Lymphotoxin-beta | 0.74 | P08235 | NR3C2 | Mineralocorticoid receptor | Q9UNE0 | EDAR | Tumor necrosis factor receptor superfamily member EDAR | 0.819 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.825 |
| Vidarabine | hsa04070 | Phosphatidylinositol signaling system | 1.67E-03 | 6 | P19174, P0DP23, P42338, O14986, P23743, P27987 | PLCG1, CALM1, PIK3CB, PIP5K1B, DGKA, ITPKB | More | | Vidarabine | hsa04071 | Sphingolipid signaling pathway | 5.21E-07 | 8 | P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Vidarabine | hsa04072 | Phospholipase D signaling pathway | 3.32E-04 | 9 | P42338, Q9UQC2, P43657, P25024, P25025, P19174, Q8WYR1, Q15438, P51828 | PIK3CB, GAB2, P2RY5, CXCR1, CXCR2, PLCG1, PIK3R5, PSCD1, ADCY7 | More | | Vidarabine | hsa04080 | Neuroactive ligand-receptor interaction | 8.70E-03 | 5 | P00734, Q96G91, Q01726, P41968, P14416 | F2, P2RY11, MC1R, MC3R, DRD2 | More | | Vidarabine | hsa04110 | Cell cycle | 3.57E-02 | 3 | Q9UBD5, P06493, P33981 | ORC3, CDK1, TTK | More | | Vidarabine | hsa04115 | p53 signaling pathway | 1.13E-06 | 9 | P24522, O15151, Q13315, Q7LG56, P31350, Q9HA38, P04637, O95067, P10415 | GADD45A, MDM4, ATM, RRM2B, RRM2, ZMAT3, TP53, CCNB2, BCL2 | More | | Vidarabine | hsa04141 | Protein processing in endoplasmic reticulum | 6.42E-03 | 8 | P18848, P30101, Q15437, Q15436, Q99941, P11142, P07900, P08238 | ATF4, PDIA3, SEC23B, SEC23A, CREBL1, HSPA8, HSP90AA1, HSP90AB1 | More | | Vidarabine | hsa04142 | Lysosome | 1.95E-04 | 8 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916, Q04900 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2, CD164 | More | | Vidarabine | hsa04144 | Endocytosis | 1.13E-03 | 14 | Q13191, P0DMV8, P11142, Q9H444, O75351, P62491, P25024, Q96B97, P43250, Q15438, Q14161, P14784, Q9UMY4, Q9Y5X3 | CBLB, HSPA1A, HSPA8, CHMP4B, VPS4B, RAB11A, CXCR1, SH3KBP1, GRK6, PSCD1, GIT2, IL2RB, SNX12, SNX5 | More | | Vidarabine | hsa04145 | Phagosome | 2.54E-04 | 8 | Q15080, P14598, Q13509, P68371, P05164, P78380, P35443, P13765 | NCF4, NCF1, TUBB3, TUBB2C, MPO, OLR1, THBS4, HLA-DOB | More | | Vidarabine | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Vidarabine | hsa04150 | mTOR signaling pathway | 3.46E-02 | 2 | P42338, P49841 | PIK3CB, GSK3B | More | | Vidarabine | hsa04151 | PI3K-Akt signaling pathway | 1.64E-03 | 21 | P62753, P42338, P43657, P27348, P20827, P49767, P07900, P08238, Q8WYR1, P62873, P63218, P50151, O15335, Q16363, Q13751, P22105, P14784, Q99941, P18848, P30279, P30281 | RPS6, PIK3CB, P2RY5, YWHAQ, EFNA1, VEGFC, HSP90AA1, HSP90AB1, PIK3R5, GNB1, GNG5, GNG10, CHAD, LAMA4, LAMB3, TNXB, IL2RB, CREBL1, ATF4, CCND2, CCND3 | More | | Vidarabine | hsa04152 | AMPK signaling pathway | 2.34E-02 | 2 | Q96EB6, P36956 | SIRT1, SREBF1 | More | | Vidarabine | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Vidarabine | hsa04211 | Longevity regulating pathway | 1.18E-02 | 3 | Q12778, Q9UEF7, Q96KQ7 | FOXO1, KL, EHMT2 | More | | Vidarabine | hsa04213 | Longevity regulating pathway - multiple species | 2.43E-04 | 7 | P42338, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Vidarabine | hsa04217 | Necroptosis | 5.13E-05 | 12 | P01568, Q13489, P98170, Q13546, P42224, P07900, P08238, P15104, P05141, Q13557, P21796, P45880 | IFNA21, BIRC3, BIRC4, RIPK1, STAT1, HSP90AA1, HSP90AB1, GLUL, SLC25A5, CAMK2D, VDAC1, VDAC2 | More | | Vidarabine | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.85E-04 | 8 | P67936, P07550, P51828, P22694, Q8WYR1, P18848, Q13362, P0DP24 | TPM4, ADRB2, ADCY7, PRKACB, PIK3R5, ATF4, PPP2R5C, CALM2 | More | | Vidarabine | hsa04270 | Vascular smooth muscle contraction | 3.79E-04 | 7 | P0DP24, P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM2, CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Vidarabine | hsa04310 | Wnt signaling pathway | 5.60E-03 | 3 | P30279, Q13485, O43318 | CCND2, SMAD4, MAP3K7 | More | | Vidarabine | hsa04330 | Notch signaling pathway | 3.28E-03 | 4 | Q92542, P49768, Q92830, P78504 | NCSTN, PSEN1, KAT2A, JAG1 | More | | Vidarabine | hsa04340 | Hedgehog signaling pathway | 1.29E-04 | 5 | P49841, P22694, Q13635, P49407, P10415 | GSK3B, PRKACB, PTCH1, ARRB1, BCL2 | More | | Vidarabine | hsa04360 | Axon guidance | 2.47E-03 | 7 | P16333, P20827, O95631, P42338, P07332, P23528, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1 | More | | Vidarabine | hsa04371 | Apelin signaling pathway | 3.02E-06 | 10 | P62873, P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Vidarabine | hsa04380 | Osteoclast differentiation | 1.79E-04 | 7 | Q9UQC2, Q16539, P42338, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, PIK3CB, IL1R1, FCGR3B, TNF, LILRA2 | More | | Vidarabine | hsa04390 | Hippo signaling pathway | 4.35E-02 | 2 | P63261, O15105 | ACTG1, SMAD7 | More | | Vidarabine | hsa04510 | Focal adhesion | 4.60E-02 | 3 | Q15942, P51636, P30281 | ZYX, CAV2, CCND3 | More | | Vidarabine | hsa04520 | Adherens junction | 3.91E-02 | 2 | Q13485, O43318 | SMAD4, MAP3K7 | More | | Vidarabine | hsa04530 | Tight junction | 3.60E-03 | 5 | P63261, P16989, P56750, Q92974, Q14247 | ACTG1, CSDA, CLDN17, ARHGEF2, CTTN | More | | Vidarabine | hsa04540 | Gap junction | 7.81E-03 | 3 | Q13509, P68371, Q9NRA1 | TUBB3, TUBB2C, PDGFC | More | | Vidarabine | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 2.16E-02 | 2 | P04628, P40189 | WNT1, IL6ST | More | | Vidarabine | hsa04610 | Complement and coagulation cascades | 4.31E-07 | 4 | P00734, P0C0L4, P05107, P21730 | F2, C4A, ITGB2, C5AR1 | More | | Vidarabine | hsa04612 | Antigen processing and presentation | 4.72E-02 | 4 | P13765, P48382, P26715, P26717 | HLA-DOB, RFX5, KLRC1, KLRC2 | More | | Vidarabine | hsa04613 | Neutrophil extracellular trap formation | 5.45E-06 | 19 | O60603, P05164, P08246, Q9UM07, P04908, Q6FI13, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Vidarabine | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | | Vidarabine | hsa04621 | NOD-like receptor signaling pathway | 1.24E-03 | 15 | Q16539, Q14643, P01568, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q13546, Q05823, P01375, P09341, P49913, P12838 | MAPK14, ITPR1, IFNA21, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RIPK1, RNASEL, TNF, CXCL1, CAMP, DEFA4 | More | | Vidarabine | hsa04622 | RIG-I-like receptor signaling pathway | 1.53E-03 | 4 | P01568, Q13546, Q12933, P10145 | IFNA21, RIPK1, TRAF2, IL8 | More | | Vidarabine | hsa04623 | Cytosolic DNA-sensing pathway | 9.06E-05 | 4 | P01584, P01568, Q13546, Q8NHW4 | IL1B, IFNA21, RIPK1, CCL4L2 | More | | Vidarabine | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Vidarabine | hsa04630 | JAK-STAT signaling pathway | 3.09E-03 | 3 | O75925, P40189, Q06124 | PIAS1, IL6ST, PTPN11 | More | | Vidarabine | hsa04640 | Hematopoietic cell lineage | 1.48E-04 | 12 | P13612, P14778, P27930, P11215, P11836, P25063, P07766, P09693, P01732, P01730, P09564, P13765 | ITGA4, IL1R1, IL1R2, ITGAM, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB | More | | Vidarabine | hsa04650 | Natural killer cell mediated cytotoxicity | 3.17E-04 | 10 | P19174, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015 | PLCG1, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B | More | | Vidarabine | hsa04657 | IL-17 signaling pathway | 3.11E-04 | 7 | O00463, Q16539, P49841, P14780, Q9UJX4, P80188, P01375 | TRAF5, MAPK14, GSK3B, MMP9, ANAPC5, LCN2, TNF | More | | Vidarabine | hsa04658 | Th1 and Th2 cell differentiation | 5.81E-13 | 14 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P32320 | CDA | Cytidine deaminase | Q04759 | PRKCQ | Protein kinase C theta type | -0.814 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.885 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P32320 | CDA | Cytidine deaminase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.749 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.804 | P32320 | CDA | Cytidine deaminase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.776 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.842 | P32320 | CDA | Cytidine deaminase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.701 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.766 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.835 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P32320 | CDA | Cytidine deaminase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.848 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.714 | P32320 | CDA | Cytidine deaminase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.863 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.867 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P32320 | CDA | Cytidine deaminase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.768 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.738 | P32320 | CDA | Cytidine deaminase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.783 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.744 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.855 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 |
| Vidarabine | hsa04659 | Th17 cell differentiation | 2.58E-14 | 20 | Q04759, Q16539, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, P40189, Q9UL17, P23771, P84022, Q13485, P07900, P08238, P07766, P09693, P20963 | PRKCQ, MAPK14, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, IL6ST, TBX21, GATA3, SMAD3, SMAD4, HSP90AA1, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.736 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.842 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.936 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.766 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.835 | P07948 | LYN | Tyrosine-protein kinase Lyn | P06239 | LCK | Tyrosine-protein kinase Lck | -0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.754 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.771 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.831 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.738 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.923 | P07948 | LYN | Tyrosine-protein kinase Lyn | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.714 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.703 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.867 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.719 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.768 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.714 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.729 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.709 | P07948 | LYN | Tyrosine-protein kinase Lyn | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.782 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.876 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.885 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.824 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.748 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.804 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.816 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.733 |
| Vidarabine | hsa04660 | T cell receptor signaling pathway | 3.09E-12 | 17 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P32320 | CDA | Cytidine deaminase | P01375 | TNF | Tumor necrosis factor | 0.806 | P32320 | CDA | Cytidine deaminase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.864 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P32320 | CDA | Cytidine deaminase | Q04759 | PRKCQ | Protein kinase C theta type | -0.814 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P32320 | CDA | Cytidine deaminase | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.801 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.727 | P32320 | CDA | Cytidine deaminase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.808 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.825 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.709 | P32320 | CDA | Cytidine deaminase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.872 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.781 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.885 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P32320 | CDA | Cytidine deaminase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.749 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.733 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.804 | P32320 | CDA | Cytidine deaminase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.776 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.816 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.766 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.759 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P32320 | CDA | Cytidine deaminase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.808 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.757 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.75 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P32320 | CDA | Cytidine deaminase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.73 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.833 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.835 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.842 | P32320 | CDA | Cytidine deaminase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.701 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.798 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.733 |
| Vidarabine | hsa04662 | B cell receptor signaling pathway | 5.84E-08 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.81 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.798 | P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.756 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 1 | P07948 | LYN | Tyrosine-protein kinase Lyn | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P60033 | CD81 | CD81 antigen | -0.835 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P60033 | CD81 | CD81 antigen | -0.714 | P07948 | LYN | Tyrosine-protein kinase Lyn | P60033 | CD81 | CD81 antigen | -0.884 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P60033 | CD81 | CD81 antigen | -0.83 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.749 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.735 | P07948 | LYN | Tyrosine-protein kinase Lyn | P07948 | LYN | Tyrosine-protein kinase Lyn | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P21854 | CD72 | B-cell differentiation antigen CD72 | -0.731 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P21854 | CD72 | B-cell differentiation antigen CD72 | -0.707 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P21854 | CD72 | B-cell differentiation antigen CD72 | -0.705 | P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | -0.751 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | 0.763 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | 0.919 | P07948 | LYN | Tyrosine-protein kinase Lyn | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | 0.843 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8N149 | LILRA2 | Leukocyte immunoglobulin-like receptor subfamily A member 2 | 0.878 |
| Vidarabine | hsa04664 | Fc epsilon RI signaling pathway | 1.75E-05 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Vidarabine | hsa04666 | Fc gamma R-mediated phagocytosis | 3.17E-03 | 4 | P42338, P23528, Q9UQC2, P14598 | PIK3CB, CFL1, GAB2, NCF1 | More | | Vidarabine | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Vidarabine | hsa04713 | Circadian entrainment | 3.99E-04 | 6 | O15399, P0DP23, Q13557, P62873, P63218, P50151 | GRIN2D, CALM1, CAMK2D, GNB1, GNG5, GNG10 | More | | Vidarabine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Vidarabine | hsa04720 | Long-term potentiation | 2.33E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Vidarabine | hsa04721 | Synaptic vesicle cycle | 3.77E-02 | 1 | P43003 | SLC1A3 | More | | Vidarabine | hsa04724 | Glutamatergic synapse | 1.56E-06 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | | Vidarabine | hsa04725 | Cholinergic synapse | 1.78E-04 | 7 | P62873, P63218, P50151, P18848, Q16566, Q13557, P42338 | GNB1, GNG5, GNG10, ATF4, CAMK4, CAMK2D, PIK3CB | More | | Vidarabine | hsa04726 | Serotonergic synapse | 2.38E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Vidarabine | hsa04727 | GABAergic synapse | 3.96E-06 | 5 | P62873, P63218, P50151, P15104, P46459 | GNB1, GNG5, GNG10, GLUL, NSF | More | | Vidarabine | hsa04728 | Dopaminergic synapse | 1.82E-04 | 12 | P14416, P62873, P63218, P50151, P49841, Q99941, P18848, Q16539, Q13557, P49407, P0DP23, P48058 | DRD2, GNB1, GNG5, GNG10, GSK3B, CREBL1, ATF4, MAPK14, CAMK2D, ARRB1, CALM1, GRIA4 | More | | Vidarabine | hsa04730 | Long-term depression | 3.20E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Vidarabine | hsa04740 | Olfactory transduction | 9.79E-03 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Vidarabine | hsa04744 | Phototransduction | 1.49E-04 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Vidarabine | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-06 | 11 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P24723, Q04759, P0DP23, P01042 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1, KNG1 | More | | Vidarabine | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Vidarabine | hsa04911 | Insulin secretion | 4.31E-02 | 2 | P22694, P18848 | PRKACB, ATF4 | More | | Vidarabine | hsa04913 | Ovarian steroidogenesis | 2.52E-02 | 1 | P06213 | INSR | More | | Vidarabine | hsa04914 | Progesterone-mediated oocyte maturation | 3.92E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | | Vidarabine | hsa04915 | Estrogen signaling pathway | 5.83E-05 | 11 | Q99941, P18848, Q08828, P51828, P07900, P08238, P0DMV8, P11142, P0DP24, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, HSP90AA1, HSP90AB1, HSPA1A, HSPA8, CALM2, CALM1, NCOA1 | More | | Vidarabine | hsa04916 | Melanogenesis | 2.82E-02 | 2 | P49841, Q01726 | GSK3B, MC1R | More | | Vidarabine | hsa04917 | Prolactin signaling pathway | 2.82E-02 | 2 | P42338, P49841 | PIK3CB, GSK3B | More | | Vidarabine | hsa04918 | Thyroid hormone synthesis | 3.46E-03 | 5 | P22694, P51828, P18848, P02768, P05543 | PRKACB, ADCY7, ATF4, ALB, SERPINA7 | More | | Vidarabine | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Vidarabine | hsa04920 | Adipocytokine signaling pathway | 4.76E-03 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Vidarabine | hsa04921 | Oxytocin signaling pathway | 2.92E-02 | 4 | P0DP24, P51828, Q96RR4, Q8WYR1 | CALM2, ADCY7, CAMKK2, PIK3R5 | More | | Vidarabine | hsa04923 | Regulation of lipolysis in adipocytes | 4.17E-04 | 5 | P22694, P07550, P06213, P42338, Q9Y4H2 | PRKACB, ADRB2, INSR, PIK3CB, IRS2 | More | | Vidarabine | hsa04924 | Renin secretion | 2.54E-04 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Vidarabine | hsa04925 | Aldosterone synthesis and secretion | 3.35E-02 | 4 | Q99941, P18848, P0DP23, Q13557 | CREBL1, ATF4, CALM1, CAMK2D | More | | Vidarabine | hsa04926 | Relaxin signaling pathway | 8.02E-04 | 6 | P42338, P63218, P50151, P49767, P30679, P49407 | PIK3CB, GNG5, GNG10, VEGFC, GNA15, ARRB1 | More | | Vidarabine | hsa04927 | Cortisol synthesis and secretion | 1.86E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Vidarabine | hsa04929 | GnRH secretion | 1.13E-03 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Vidarabine | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | | Vidarabine | hsa04931 | Insulin resistance | 9.16E-04 | 5 | P01375, P49841, Q06124, P06737, Q9Y478 | TNF, GSK3B, PTPN11, PYGL, PRKAB1 | More | | Vidarabine | hsa04932 | Non-alcoholic fatty liver disease | 9.65E-04 | 9 | P49841, O43521, O75460, P01584, P13073, P12074, Q16718, O95298, O14521 | GSK3B, BCL2L11, ERN1, IL1B, COX4I1, COX6A1, NDUFA5, NDUFC2, SDHD | More | | Vidarabine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Vidarabine | hsa04934 | Cushing syndrome | 2.84E-02 | 3 | P18848, P22694, P46527 | ATF4, PRKACB, CDKN1B | More | | Vidarabine | hsa04940 | Type I diabetes mellitus | 2.99E-02 | 2 | P10747, P01375 | CD28, TNF | More | | Vidarabine | hsa04950 | Maturity onset diabetes of the young | 8.73E-04 | 1 | P35557 | GCK | More | | Vidarabine | hsa04960 | Aldosterone-regulated sodium reabsorption | 6.19E-04 | 3 | P06213, P42338, P48048 | INSR, PIK3CB, KCNJ1 | More | | Vidarabine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.53E-03 | 2 | P00918, P49448 | CA2, GLUD2 | More | | Vidarabine | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Vidarabine | hsa04970 | Salivary secretion | 1.77E-03 | 6 | P07550, Q08828, P51828, P22694, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, CALM1, CAMP | More | | Vidarabine | hsa04971 | Gastric acid secretion | 3.46E-02 | 2 | P48048, P78508 | KCNJ1, KCNJ10 | More | | Vidarabine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Vidarabine | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | | Vidarabine | hsa04976 | Bile secretion | 1.90E-04 | 6 | O43315, Q08828, P51828, P22694, P08183, Q14032 | AQP9, ADCY1, ADCY7, PRKACB, ABCB1, BAAT | More | | Vidarabine | hsa05010 | Alzheimer disease | 4.56E-02 | 9 | P19404, P13073, P0DP23, P18848, Q71U36, Q13509, P05141, P21796, P45880 | NDUFV2, COX4I1, CALM1, ATF4, TUBA1A, TUBB3, SLC25A5, VDAC1, VDAC2 | More | | Vidarabine | hsa05012 | Parkinson disease | 6.70E-04 | 11 | P19404, P13073, P05141, P21796, P45880, P18848, P19174, P0DP23, Q13557, Q71U36, Q13509 | NDUFV2, COX4I1, SLC25A5, VDAC1, VDAC2, ATF4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3 | More | | Vidarabine | hsa05016 | Huntington disease | 5.53E-06 | 19 | O95298, P19404, P13073, P12074, Q13547, Q9GZM3, P24928, P30876, P62487, P52435, P05141, P21796, P45880, Q9NYC9, O75460, Q71U36, Q13509, P28070, O00232 | NDUFC2, NDUFV2, COX4I1, COX6A1, HDAC1, POLR2J2, POLR2A, POLR2B, POLR2G, POLR2J, SLC25A5, VDAC1, VDAC2, DNAH9, ERN1, TUBA1A, TUBB3, PSMB4, PSMD12 | More | | Vidarabine | hsa05017 | Spinocerebellar ataxia | 1.32E-03 | 6 | Q92915, Q8TB72, O15399, P42338, P28074, P21796 | FGF14, PUM2, GRIN2D, PIK3CB, PSMB5, VDAC1 | More | | Vidarabine | hsa05020 | Prion disease | 9.73E-04 | 14 | P11142, Q16718, P19404, O14521, P13073, P18848, P05141, P21796, P45880, Q71U36, Q13509, P49841, Q99941, Q16539 | HSPA8, NDUFA5, NDUFV2, SDHD, COX4I1, ATF4, SLC25A5, VDAC1, VDAC2, TUBA1A, TUBB3, GSK3B, CREBL1, MAPK14 | More | | Vidarabine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 6.33E-04 | 18 | Q71U36, Q13509, P49841, Q16718, P19404, O14521, P13073, P21796, P18848, Q13561, P19174, P05141, P45880, P20333, Q16539, Q08752, P0DP23, Q13557 | TUBA1A, TUBB3, GSK3B, NDUFA5, NDUFV2, SDHD, COX4I1, VDAC1, ATF4, DCTN2, PLCG1, SLC25A5, VDAC2, TNFRSF1B, MAPK14, PPID, CALM1, CAMK2D | More | | Vidarabine | hsa05030 | Cocaine addiction | 4.31E-02 | 2 | P22694, P18848 | PRKACB, ATF4 | More | | Vidarabine | hsa05031 | Amphetamine addiction | 6.57E-03 | 5 | P0DP23, Q13557, Q99941, P18848, Q13547 | CALM1, CAMK2D, CREBL1, ATF4, HDAC1 | More | | Vidarabine | hsa05032 | Morphine addiction | 3.52E-04 | 5 | P62873, P63218, P50151, Q07343, P43250 | GNB1, GNG5, GNG10, PDE4B, GRK6 | More | | Vidarabine | hsa05034 | Alcoholism | 3.07E-06 | 14 | O15399, Q99941, P18848, Q16566, Q13547, P0DP23, P62873, P63218, P50151, Q93077, P62807, Q93079, O60814, P68431 | GRIN2D, CREBL1, ATF4, CAMK4, HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Vidarabine | hsa05100 | Bacterial invasion of epithelial cells | 4.50E-02 | 1 | Q92529 | SHC3 | More | | Vidarabine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.28E-07 | 9 | Q16539, Q99437, P09341, P19875, P19174, P25024, P25025, P41240, P07948 | MAPK14, ATP6V0B, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, CSK, LYN | More | | Vidarabine | hsa05131 | Shigellosis | 1.80E-02 | 5 | Q13546, Q9UDY8, Q12778, Q13315, P10415 | RIPK1, MALT1, FOXO1, ATM, BCL2 | More | | Vidarabine | hsa05132 | Salmonella infection | 1.63E-03 | 6 | Q13546, Q13489, P10415, O60282, Q13509, P68371 | RIPK1, BIRC3, BCL2, KIF5C, TUBB3, TUBB2C | More | | Vidarabine | hsa05133 | Pertussis | 8.35E-05 | 3 | P05107, P10145, P0C0L4 | ITGB2, IL8, C4A | More | | Vidarabine | hsa05134 | Legionellosis | 1.03E-04 | 8 | P01584, Q9NR31, P11215, P68104, P0DMV8, P11142, P09341, P19875 | IL1B, SAR1A, ITGAM, EEF1A1, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Vidarabine | hsa05135 | Yersinia infection | 1.66E-02 | 6 | P13612, P06239, Q16539, P49841, P01730, P01732 | ITGA4, LCK, MAPK14, GSK3B, CD4, CD8A | More | | Vidarabine | hsa05143 | African trypanosomiasis | 7.35E-04 | 2 | P69905, P68871 | HBA2, HBB | More | | Vidarabine | hsa05144 | Malaria | 4.24E-06 | 8 | P69905, P68871, O60603, P01375, P05107, P35443, P10145, P26718 | HBA2, HBB, TLR2, TNF, ITGB2, THBS4, IL8, KLRK1 | More | | Vidarabine | hsa05145 | Toxoplasmosis | 3.55E-02 | 3 | P23458, Q8WYR1, P0DMV8 | JAK1, PIK3R5, HSPA1A | More | | Vidarabine | hsa05146 | Amoebiasis | 8.39E-08 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Vidarabine | hsa05150 | Staphylococcus aureus infection | 5.19E-05 | 12 | P0C0L4, P21730, P21462, O75015, P13765, P13646, Q14532, P05107, P59665, P59666, P12838, P49913 | C4A, C5AR1, FPR1, FCGR3B, HLA-DOB, KRT13, KRT32, ITGB2, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Vidarabine | hsa05152 | Tuberculosis | 1.16E-03 | 10 | O75015, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, Q16539, P51617 | FCGR3B, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, MAPK14, IRAK1 | More | | Vidarabine | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Vidarabine | hsa05163 | Human cytomegalovirus infection | 5.02E-08 | 19 | P42338, P01375, P62873, P63218, P50151, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, O00463, P30101, P01568 | PIK3CB, TNF, GNB1, GNG5, GNG10, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, TRAF5, PDIA3, IFNA21 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.756 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.736 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.754 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.766 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.81 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.798 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.733 | P51531 | SMARCA2 | Probable global transcription activator SNF2L2 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.746 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.923 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.854 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.713 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.799 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.797 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.892 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.774 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.842 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.786 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.735 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | -0.721 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | -0.825 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 |
| Vidarabine | hsa05165 | Human papillomavirus infection | 9.48E-04 | 8 | P46527, P35443, P01375, Q08999, Q9UM47, P22694, Q13362, Q13315 | CDKN1B, THBS4, TNF, RBL2, NOTCH3, PRKACB, PPP2R5C, ATM | More | | Vidarabine | hsa05166 | Human T-cell leukemia virus 1 infection | 4.93E-02 | 6 | P22694, P18848, P25963, P25208, Q13315, P01375 | PRKACB, ATF4, NFKBIA, NFYB, ATM, TNF | More | | Vidarabine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.98E-03 | 9 | P01568, P42224, P62873, P63218, P50151, P19875, P19174, P07948, P0DP23 | IFNA21, STAT1, GNB1, GNG5, GNG10, CXCL2, PLCG1, LYN, CALM1 | More | | Vidarabine | hsa05168 | Herpes simplex virus 1 infection | 1.78E-03 | 13 | P01568, P42224, Q07955, Q01130, P84103, Q13243, Q13489, P30101, P42338, Q13398, Q03923, Q9NZL3, Q9UDV6 | IFNA21, STAT1, SFRS1, SFRS2, SFRS3, SFRS5, BIRC3, PDIA3, PIK3CB, ZNF211, ZNF85, ZNF224, ZNF212 | More | | Vidarabine | hsa05169 | Epstein-Barr virus infection | 3.52E-05 | 16 | P13765, Q13547, O00463, Q16539, P42338, P07948, P30101, Q13761, P24522, O75293, P30279, P42224, P29728, P07766, P09693, P20963 | HLA-DOB, HDAC1, TRAF5, MAPK14, PIK3CB, LYN, PDIA3, RUNX3, GADD45A, GADD45B, CCND2, STAT1, OAS2, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.738 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.799 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q13547 | HDAC1 | Histone deacetylase 1 | -0.774 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13547 | HDAC1 | Histone deacetylase 1 | 0.713 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.786 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.842 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 1 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.749 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.735 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.732 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | -0.721 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.881 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.744 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.708 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.772 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.793 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.768 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.772 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P30279 | CCND2 | G1/S-specific cyclin-D2 | 0.731 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.754 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | -0.805 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.885 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.77 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.748 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.804 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.823 |
| Vidarabine | hsa05170 | Human immunodeficiency virus 1 infection | 4.81E-04 | 20 | P62873, P63218, P50151, P0DP23, P01375, O00463, P30101, Q14643, P01568, P01730, Q16539, O60603, Q13315, P23528, P07766, P09693, P20963, P10415, Q93034, Q9Y6Q5 | GNB1, GNG5, GNG10, CALM1, TNF, TRAF5, PDIA3, ITPR1, IFNA21, CD4, MAPK14, TLR2, ATM, CFL1, CD3E, CD3G, CD247, BCL2, CUL5, AP1M2 | More | | Vidarabine | hsa05200 | Pathways in cancer | 4.31E-09 | 33 | Q16363, Q13751, P42338, P07900, P08238, P42224, P19174, P43246, P84022, Q13485, P20585, P52701, Q13547, P14923, P30279, P30281, Q13489, P98170, P49767, P43657, P62873, P63218, P50151, Q14344, Q7LDG7, P78417, O75293, P0DP23, Q13557, P01568, P14784, P40189, P01042 | LAMA4, LAMB3, PIK3CB, HSP90AA1, HSP90AB1, STAT1, PLCG1, MSH2, SMAD3, SMAD4, MSH3, MSH6, HDAC1, JUP, CCND2, CCND3, BIRC3, BIRC4, VEGFC, P2RY5, GNB1, GNG5, GNG10, GNA13, RASGRP2, GSTO1, GADD45B, CALM1, CAMK2D, IFNA21, IL2RB, IL6ST, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q16363 | LAMA4 | Laminin subunit alpha-4 | 0.793 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.709 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.876 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.754 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.936 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P29375 | JARID1A | Lysine-specific demethylase 5A | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.87 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.802 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.794 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P20585 | MSH3 | DNA mismatch repair protein Msh3 | 0.715 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P52701 | MSH6 | DNA mismatch repair protein Msh6 | 0.91 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13547 | HDAC1 | Histone deacetylase 1 | 0.713 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14923 | JUP | Junction plakoglobin | -0.735 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P30279 | CCND2 | G1/S-specific cyclin-D2 | 0.704 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P30279 | CCND2 | G1/S-specific cyclin-D2 | 0.731 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.746 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.707 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.818 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | O43318 | MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.849 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | P29375 | JARID1A | Lysine-specific demethylase 5A | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.748 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.772 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P0DP23 | CALM1 | Calmodulin-1 | 0.804 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.745 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.831 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | P01042 | KNG1 | Kininogen-1 | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 |
| Vidarabine | hsa05202 | Transcriptional misregulation in cancer | 9.19E-09 | 20 | Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13077, O15550, P46527, P04637, P35226, P05164, P12838, P08246, Q9C0K0, Q92769, P12980, P24522 | SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, TRAF1, UTX, CDKN1B, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P21589 | NT5E | 5'-nucleotidase | Q15532 | SS18 | Protein SSXT | 0.77 | P32320 | CDA | Cytidine deaminase | Q15532 | SS18 | Protein SSXT | -0.722 | P22748 | CA4 | Carbonic anhydrase 4 | Q15532 | SS18 | Protein SSXT | -0.862 | P04183 | TK1 | Thymidine kinase, cytosolic | Q13315 | ATM | Serine-protein kinase ATM | -0.765 | P32320 | CDA | Cytidine deaminase | Q13315 | ATM | Serine-protein kinase ATM | -0.748 | P49913 | CAMP | Cathelicidin antimicrobial peptide | Q13315 | ATM | Serine-protein kinase ATM | -0.775 | P32320 | CDA | Cytidine deaminase | P41732 | TSPAN7 | Tetraspanin-7 | 0.736 | P22748 | CA4 | Carbonic anhydrase 4 | P41732 | TSPAN7 | Tetraspanin-7 | 0.706 | P32320 | CDA | Cytidine deaminase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.951 | P22748 | CA4 | Carbonic anhydrase 4 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.925 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.74 | P32320 | CDA | Cytidine deaminase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.766 | P22748 | CA4 | Carbonic anhydrase 4 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.708 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.701 | P04183 | TK1 | Thymidine kinase, cytosolic | P14923 | JUP | Junction plakoglobin | -0.774 | P21589 | NT5E | 5'-nucleotidase | P14923 | JUP | Junction plakoglobin | 0.87 | P22748 | CA4 | Carbonic anhydrase 4 | P14923 | JUP | Junction plakoglobin | -0.772 | P04183 | TK1 | Thymidine kinase, cytosolic | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.781 | P32320 | CDA | Cytidine deaminase | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.761 | P32320 | CDA | Cytidine deaminase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.852 | P22748 | CA4 | Carbonic anhydrase 4 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.833 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.742 | P32320 | CDA | Cytidine deaminase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.723 | P22748 | CA4 | Carbonic anhydrase 4 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.718 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.788 | P21589 | NT5E | 5'-nucleotidase | O15550 | UTX | Lysine-specific demethylase 6A | -0.78 | P22748 | CA4 | Carbonic anhydrase 4 | O15550 | UTX | Lysine-specific demethylase 6A | 0.714 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P46527 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | -0.8 | P21589 | NT5E | 5'-nucleotidase | P04637 | TP53 | Cellular tumor antigen p53 | 0.701 | P32320 | CDA | Cytidine deaminase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.828 | P22748 | CA4 | Carbonic anhydrase 4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.834 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.723 | P32320 | CDA | Cytidine deaminase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.828 | P22748 | CA4 | Carbonic anhydrase 4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.834 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.723 | P04183 | TK1 | Thymidine kinase, cytosolic | P05164 | MPO | Myeloperoxidase | 0.917 | P21589 | NT5E | 5'-nucleotidase | P05164 | MPO | Myeloperoxidase | -0.706 | P32320 | CDA | Cytidine deaminase | P05164 | MPO | Myeloperoxidase | 0.909 | P22748 | CA4 | Carbonic anhydrase 4 | P05164 | MPO | Myeloperoxidase | 0.826 | P32320 | CDA | Cytidine deaminase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.822 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P12838 | DEFA4 | Neutrophil defensin 4 | -0.719 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P12838 | DEFA4 | Neutrophil defensin 4 | 0.718 | P04183 | TK1 | Thymidine kinase, cytosolic | P08246 | ELA2 | Neutrophil elastase | 0.838 | P32320 | CDA | Cytidine deaminase | P08246 | ELA2 | Neutrophil elastase | 0.92 | P22748 | CA4 | Carbonic anhydrase 4 | P08246 | ELA2 | Neutrophil elastase | 0.921 | P49913 | CAMP | Cathelicidin antimicrobial peptide | P08246 | ELA2 | Neutrophil elastase | 0.807 | P04183 | TK1 | Thymidine kinase, cytosolic | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.783 | P32320 | CDA | Cytidine deaminase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.867 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.729 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q92769 | HDAC2 | Histone deacetylase 2 | 0.735 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P12980 | LYL1 | Protein lyl-1 | -0.709 | P04183 | TK1 | Thymidine kinase, cytosolic | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.718 | P32320 | CDA | Cytidine deaminase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | P22748 | CA4 | Carbonic anhydrase 4 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.769 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.737 |
| Vidarabine | hsa05203 | Viral carcinogenesis | 2.25E-06 | 19 | Q08999, Q12933, Q99941, P18848, P42229, P06746, P07948, P30279, P27348, P29083, Q7KZF4, P46527, Q13547, Q15283, P06396, P25963, P22694, P62807, O60814 | RBL2, TRAF2, CREBL1, ATF4, STAT5A, POLB, LYN, CCND2, YWHAQ, GTF2E1, SND1, CDKN1B, HDAC1, RASA2, GSN, NFKBIA, PRKACB, HIST1H2BC, H2BC12 | More | | Vidarabine | hsa05204 | Chemical carcinogenesis | 1.77E-04 | 4 | Q16772, P09211, P78417, P11712 | GSTA3, GSTP1, GSTO1, CYP2C9 | More | | Vidarabine | hsa05206 | MicroRNAs in cancer | 1.67E-02 | 4 | P46527, Q9UM47, P35226, Q13315 | CDKN1B, NOTCH3, BMI1, ATM | More | | Vidarabine | hsa05210 | Colorectal cancer | 7.33E-03 | 5 | P84022, Q13485, P43246, P52701, O75293 | SMAD3, SMAD4, MSH2, MSH6, GADD45B | More | | Vidarabine | hsa05212 | Pancreatic cancer | 1.92E-04 | 5 | P42338, P42224, P84022, Q13485, O75293 | PIK3CB, STAT1, SMAD3, SMAD4, GADD45B | More | | Vidarabine | hsa05213 | Endometrial cancer | 2.82E-02 | 2 | P49841, P42338 | GSK3B, PIK3CB | More | | Vidarabine | hsa05214 | Glioma | 7.31E-05 | 6 | P0DP23, Q16566, Q13557, P42338, P19174, O75293 | CALM1, CAMK4, CAMK2D, PIK3CB, PLCG1, GADD45B | More | | Vidarabine | hsa05215 | Prostate cancer | 9.10E-04 | 6 | P10415, Q12778, Q9NRA1, P49841, P42338, P27930 | BCL2, FOXO1, PDGFC, GSK3B, PIK3CB, IL1R2 | More | | Vidarabine | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Vidarabine | hsa05221 | Acute myeloid leukemia | 3.29E-02 | 3 | P14923, Q15744, P05164 | JUP, CEBPE, MPO | More | | Vidarabine | hsa05222 | Small cell lung cancer | 3.80E-02 | 4 | Q13751, Q13489, P98170, O75293 | LAMB3, BIRC3, BIRC4, GADD45B | More | | Vidarabine | hsa05224 | Breast cancer | 4.88E-02 | 2 | P42338, P49841 | PIK3CB, GSK3B | More | | Vidarabine | hsa05225 | Hepatocellular carcinoma | 3.69E-02 | 3 | P42338, P49841, P51531 | PIK3CB, GSK3B, SMARCA2 | More | | Vidarabine | hsa05226 | Gastric cancer | 2.94E-02 | 2 | P04628, P10826 | WNT1, RARB | More | | Vidarabine | hsa05231 | Choline metabolism in cancer | 2.00E-02 | 2 | Q9Y259, P49619 | CHKB, DGKG | More | | Vidarabine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.39E-09 | 12 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.727 | P32320 | CDA | Cytidine deaminase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.808 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.825 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.885 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.755 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P32320 | CDA | Cytidine deaminase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.749 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.778 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.733 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.804 | P32320 | CDA | Cytidine deaminase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.776 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.816 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.835 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P06239 | LCK | Tyrosine-protein kinase Lck | -0.791 | P32320 | CDA | Cytidine deaminase | O60603 | TLR2 | Toll-like receptor 2 | 0.864 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | O60603 | TLR2 | Toll-like receptor 2 | -0.722 | P32320 | CDA | Cytidine deaminase | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.801 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P32320 | CDA | Cytidine deaminase | Q04759 | PRKCQ | Protein kinase C theta type | -0.814 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q04759 | PRKCQ | Protein kinase C theta type | -0.737 | P60891 | PRPS1 | Ribose-phosphate pyrophosphokinase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.736 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.842 | P32320 | CDA | Cytidine deaminase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.701 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.802 | P11169 | SLC2A3 | Solute carrier family 2, facilitated glucose transporter member 3 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.766 | P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.857 |
| Vidarabine | hsa05310 | Asthma | 1.68E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Vidarabine | hsa05321 | Inflammatory bowel disease | 4.67E-05 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Vidarabine | hsa05322 | Systemic lupus erythematosus | 2.77E-04 | 13 | O75015, P08246, P08311, P09871, P01375, P10747, P13765, Q6FI13, Q93077, P62807, O60814, P68431, P05455 | FCGR3B, ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SSB | More | | Vidarabine | hsa05323 | Rheumatoid arthritis | 2.84E-02 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Vidarabine | hsa05330 | Allograft rejection | 4.31E-02 | 2 | P10747, P01375 | CD28, TNF | More | | Vidarabine | hsa05332 | Graft-versus-host disease | 1.64E-04 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Vidarabine | hsa05340 | Primary immunodeficiency | 3.99E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Vidarabine | hsa05410 | Hypertrophic cardiomyopathy | 2.60E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Vidarabine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Vidarabine | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | | Vidarabine | hsa05418 | Fluid shear stress and atherosclerosis | 1.02E-05 | 11 | Q16539, P42338, Q14145, P14598, P10599, P14780, P01375, P14778, P27930, P0DP23, P08238 | MAPK14, PIK3CB, KEAP1, NCF1, TXN, MMP9, TNF, IL1R1, IL1R2, CALM1, HSP90AB1 | More | | |